Background and Purpose-Detection of large, hypoattenualed brain-tissue volu
me on hyperacute CT scan has been suggested as an exclusion criterion for e
arly intravenous tissue plasminogen activator (IV-tPA) treatment. This stud
y assessed the reliability of detection for these findings and their relati
onship to outcome.
Methods-Fifty hyperacute CT scans (<6 hours after ictus) were selected from
a randomized trial evaluating IV-tPA (ATLANTIS trial). Three neuroradiolog
ists blinded to all clinical information evaluated scans for degree of MCA
territory involvement (<33% or >33%) and the presence of a hyperdense MCA.
Evaluations were compared with 24-hour scan results, 30-day infarct volumes
, and baseline NIH stroke scale scores (NIHSS),
Results-Readers reliably evaluated the degree of MCA territory hypodensity
(intraclass correlation = 0.53, P < 0.001), with all 3 readers agreeing in
36 of 50 cases (72%). They correctly called >33% involvement with a sensiti
vity of 60% to 85% and a specificity of 86% to 97%, The baseline NIHSS was
higher when >33% MCA hypodensity was seen (P = 0.021). Detection of signifi
cant hypodensity (>33%) correlated with poorer outcome. When >33% hypodensi
ty was not detected, mean 30-day infarct volumes were 27.0 to 33.0 cm(3), v
ersus 84.3 to 123.1 hypodensity was present (P = 0.002). cm(3) when >33%
Conclusions-Detection of MCA territory hypodensity on hyperacute CT scans i
s a sensitive, prognostic, and reliable indicator of the amount of MCA terr
itory undergoing infarction.